Determination of fexofenadine enantiomers in human plasma with high-performance liquid chromatography

被引:42
作者
Miura, Masatomo
Uno, Tsukasa
Tateishi, Tomonori
Suzuki, Toshio
机构
[1] Akita Univ Hosp, Dept Pharm, Akita 0108543, Japan
[2] Hirosaki Univ, Sch Med, Dept Clin Pharmacol, Hirosaki, Aomori, Japan
关键词
fexofenadine; enantiomer; HPLC; human plasma;
D O I
10.1016/j.jpba.2006.07.033
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A simple and sensitive high-performance liquid chromatography (HPLC) method was developed as an assay for fexofenadine enantiomers in human plasma. Fexofenadine enantiomers were separated using a mobile phase of 0.5% KH2PO4-acetonitrile (65:35, v/v) on a Chiral CD-Ph column at a flow rate of 0.5 ml/min and measurement at 220 nm. Analysis required 400 mu l of plasma and involved solid-phase extraction with an Oasis HLB cartridge, which gave recoveries for both enantiomers from 67.4 to 71.8%. The lower limit of quantification was 25 ng/ml for (R)and (S)-fexofenadine. The linear range of this assay was between 25 and 625 ng/ml (regression line r(2) > 0.993). Inter- and intra-day coefficients of variation were less than 13.6% and accuracies were within 8.8% over the linear range for both analytes. This method can be applied effectively to measure fexofenadine enantiomer concentrations in clinical samples. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:741 / 745
页数:5
相关论文
共 9 条
[1]   DETERMINATION OF TERFENADINE AND TERFENADINE ACID METABOLITE IN PLASMA USING SOLID-PHASE EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
COUTANT, JE ;
WESTMARK, PA ;
NARDELLA, PA ;
WALTER, SM ;
OKERHOLM, RA .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 570 (01) :139-148
[2]  
Cvetkovic M, 1999, DRUG METAB DISPOS, V27, P866
[3]  
Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, 2001, GUID IND BIOAN METH
[4]   The effect of rifampin administration on the disposition of fexofenadine [J].
Hamman, MA ;
Bruce, MA ;
Haehner-Daniels, BD ;
Hall, SD .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :114-121
[5]  
Robbins DK, 1998, BIOPHARM DRUG DISPOS, V19, P455, DOI 10.1002/(SICI)1099-081X(199810)19:7<455::AID-BDD130>3.0.CO
[6]  
2-W
[7]   ANALYTICAL METHODS VALIDATION - BIOAVAILABILITY, BIOEQUIVALENCE AND PHARMACOKINETIC STUDIES [J].
SHAH, VP ;
MIDHA, KK ;
DIGHE, S ;
MCGILVERAY, IJ ;
SKELLY, JP ;
YACOBI, A ;
LAYLOFF, T ;
VISWANATHAN, CT ;
COOK, CE ;
MCDOWALL, RD ;
PITTMAN, KA ;
SPECTOR, S ;
ALBERT, KS ;
BOLTON, S ;
COOK, CE ;
DIGHE, S ;
DOBRINSKA, M ;
DOUB, W ;
EICHELBAUM, M ;
FINDLAY, JWA ;
GALLICANO, K ;
GARLAND, W ;
HARDY, DJ ;
HULSE, JD ;
KARNES, HT ;
MCDOWALL, RD ;
LANGE, R ;
LAYLOFF, T ;
MASON, WD ;
MCKAY, G ;
MCGILVERAY, IJ ;
MIDHA, KK ;
ORMSBY, E ;
OVERPECK, J ;
PITTMAN, KA ;
PLATTENBERG, HD ;
SHAH, VP ;
SHIU, G ;
SITAR, D ;
SKELLY, JP ;
SORGEL, F ;
SPECTOR, S ;
STEWART, JT ;
VISWANATHAN, CT ;
YACOBI, A ;
YUH, L .
PHARMACEUTICAL RESEARCH, 1992, 9 (04) :588-592
[8]   A SENSITIVE HPLC METHOD FOR THE DETERMINATION OF TERFENADINE AND ITS METABOLITE IN HUMAN PLASMA [J].
SURAPANENI, S ;
KHALIL, SKW .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1994, 17 (11) :2419-2428
[9]   Liquid chromatographic determination of fexofenadine in human plasma with fluorescence detection [J].
Uno, T ;
Yasui-Furukori, N ;
Takahata, T ;
Sugawara, K ;
Tateishi, T .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (04) :937-942